The wound care management market comprises of dressings, equipment and other aids to prevent and treat wounds and quicken or promote wound healing. Automated suturing devices are medical devices used for sealing tissue after surgery. GlobalData uses proprietary data and analytics to provide a comprehensive report on the automated suturing devices devices market, including market shares of different players within France. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the automated suturing devices market in France was Medtronic followed by Boston Scientific, Apollo Endosurgery, B. Braun Melsungen and Ethicon.
Automated suturing devices are majorly used in suturing procedures such as minimally invasive surgeries and open surgeries. The usage of this device is negligible in the treatment of wounds, minor and major trauma cases which can be treated with the help of hand suturing techniques. Automated suturing devices are segmented into disposable automated suturing devices and reusable automated suturing devices. Disposable automated suturing devices are single use devices. Reusable automated suturing devices can be easily sterilized by standard hospital processes and reused.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the automated suturing devices devices market within France was expected to be over $10m in 2022.
For the latest complete market share analysis of automated suturing devices device market in France, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
